跳至主要内容
临床试验/ACTRN12622000345785
ACTRN12622000345785尚未招募未知

Feasibility and Efficacy of a Multidisciplinary Therapy Coaching Program For Individuals With Premanifest and Manifest Huntington's Disease

Perpetual Limited0 个研究点目标入组 84 人开始时间: 2022年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Forty-two individuals with premanifest HD (CAG > 39, DBS > 250, UHDRS-TMS < 5) and 42 individuals with early manifest HD (CAG > 39, UHDRS-TMS > 5, TFC > 7) will be recruited for this trial (effect size: f = .25, a = .05 and power (1- ß) = 80%). Participants will be required to provide written and informed consent prior to undertaking any study procedures.

排除标准

  • Exclusion criteria for participants will include concomitant cardiovascular, metabolic, immunological, neurological and musculoskeletal conditions as well as recent or ongoing substance abuse.

研究者

发起方
Perpetual Limited

相似试验

Multidisciplinary Therapy Coaching Program For... | 临床试验